Baidu
map

十九大风采录 打出中西医结合治癌组合拳

2017-10-22 朱蕗鋆 中国中医

林丽珠是广州中医药大学第一附属医院肿瘤中心主任、第一临床医学院肿瘤学教研室主任,擅长中医、中西医结合治疗中晚期恶性肿瘤。有着31年党龄的她,始终践行党员先锋模范作用,坚持以病人为中心,坚持中西医结合肿瘤学科优势,践行大医精诚理念,为患者撑起一片蓝天。

林丽珠是广州中医药大学第一附属医院肿瘤中心主任、第一临床医学院肿瘤学教研室主任,擅长中医、中西医结合治疗中晚期恶性肿瘤。有着31年党龄的她,始终践行党员先锋模范作用,坚持以病人为中心,坚持中西医结合肿瘤学科优势,践行大医精诚理念,为患者撑起一片蓝天。

10月18日,中国共产党第十九次全国代表大会在京开幕,习近平代表第十八届中央委员会向大会作报告时提出,坚持中西医并重,传承发展中医药事业。林丽珠认真学习报告内容后表示,习近平总书记的讲话,既有高度,也十分接地气,处处都是关注民生、重视民生、保障民生、改善民生的话语。近年来,国家对中医药事业的发展给予很大的政策支持,中医药人更要珍惜和利用好政策与机会,充分发挥中医药特色和优势,在建设健康中国、保障人民健康方面作出应有贡献。并且要做好中医药行业的自律和规范,让行业可持续性发展,实现良性循环。

林丽珠从1986年大学毕业留院工作起就一直兢兢业业,在临床的摸爬滚打中,逐步创出一条西为中用、中西结合挑战癌症的新路。在林丽珠带领下,其团队摸索出治肺癌的益气除痰法,治肝癌的保肝抑瘤法,治肠癌的祛瘀解毒法等癌症治疗方法,使该院肿瘤中心迅速发展,从一片空白到如今拥有189张床位,科室规模在全国同行业中处于领先地位。

林丽珠一直谨记“健康所系,性命相托”的医学誓言,坚持全心全意为人民服务的宗旨,牢记一名党员的职责和使命,工作上认真谦和、以身作则。林丽珠说,作为一名党员,就要对得起人民群众对党的期待和信赖。“当病人感觉到医生在尽心尽力为他服务时,即使病情较重,他们也能多一份安全感,安心治病、养病。”

很多来找林丽珠看病的患者都是经过多方治疗无效的危重症患者,其中不少患者家里已经因病致贫,林丽珠总是将心比心、以心换心、换位思考,重视对患者的人文关怀。无论是新患者,还是旧病号,她都会综合考虑,尽可能制定最适宜患者的治疗方案。很多患者及家属对肿瘤的认识存在偏差,不配合治疗,每遇到这种情况林丽珠都耐心地解释,以求患者达到最佳治疗效果。

同时,林丽珠带领团队建立了“林丽珠劳模创新工作室”,向老百姓传播防癌抗癌、癌症康复护理等科普知识,组织青年志愿者开展各种活动,及时为诊室外患者及家属答疑。2015年林丽珠获得了全国先进工作者称号,林丽珠所在科室在2017年被评为国家卫生计生委先进集体,并获得爱心科室称号。

“当选党的十九大代表,既是一种荣誉,更是一种责任。”林丽珠表示,将不负重托,认真履行党代表的职责,同时竭己所能,传递中医药声音。她还表示,一定会努力工作,不忘初心,扎根中医药临床和科研,为中医药事业的发展作出自己的贡献。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1748858, encodeId=ae121e4885854, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636278, encodeId=421616362e8fe, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Sun Mar 18 02:38:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717567, encodeId=439d1e17567c0, content=<a href='/topic/show?id=c05be7634e8' target=_blank style='color:#2F92EE;'>#组合拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77634, encryptionId=c05be7634e8, topicName=组合拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed332427480, createdName=hxj0128, createdTime=Wed May 09 15:38:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797152, encodeId=a0781e97152b3, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 07 18:38:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463027, encodeId=e91d146302e3a, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Mon Oct 23 23:38:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255070, encodeId=c2582550e022, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 22 10:06:39 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255056, encodeId=5e5d2550566f, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 22 09:19:51 CST 2017, time=2017-10-22, status=1, ipAttribution=)]
    2018-05-13 yinhl1990
  2. [GetPortalCommentsPageByObjectIdResponse(id=1748858, encodeId=ae121e4885854, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636278, encodeId=421616362e8fe, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Sun Mar 18 02:38:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717567, encodeId=439d1e17567c0, content=<a href='/topic/show?id=c05be7634e8' target=_blank style='color:#2F92EE;'>#组合拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77634, encryptionId=c05be7634e8, topicName=组合拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed332427480, createdName=hxj0128, createdTime=Wed May 09 15:38:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797152, encodeId=a0781e97152b3, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 07 18:38:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463027, encodeId=e91d146302e3a, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Mon Oct 23 23:38:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255070, encodeId=c2582550e022, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 22 10:06:39 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255056, encodeId=5e5d2550566f, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 22 09:19:51 CST 2017, time=2017-10-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1748858, encodeId=ae121e4885854, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636278, encodeId=421616362e8fe, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Sun Mar 18 02:38:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717567, encodeId=439d1e17567c0, content=<a href='/topic/show?id=c05be7634e8' target=_blank style='color:#2F92EE;'>#组合拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77634, encryptionId=c05be7634e8, topicName=组合拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed332427480, createdName=hxj0128, createdTime=Wed May 09 15:38:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797152, encodeId=a0781e97152b3, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 07 18:38:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463027, encodeId=e91d146302e3a, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Mon Oct 23 23:38:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255070, encodeId=c2582550e022, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 22 10:06:39 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255056, encodeId=5e5d2550566f, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 22 09:19:51 CST 2017, time=2017-10-22, status=1, ipAttribution=)]
    2018-05-09 hxj0128
  4. [GetPortalCommentsPageByObjectIdResponse(id=1748858, encodeId=ae121e4885854, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636278, encodeId=421616362e8fe, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Sun Mar 18 02:38:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717567, encodeId=439d1e17567c0, content=<a href='/topic/show?id=c05be7634e8' target=_blank style='color:#2F92EE;'>#组合拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77634, encryptionId=c05be7634e8, topicName=组合拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed332427480, createdName=hxj0128, createdTime=Wed May 09 15:38:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797152, encodeId=a0781e97152b3, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 07 18:38:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463027, encodeId=e91d146302e3a, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Mon Oct 23 23:38:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255070, encodeId=c2582550e022, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 22 10:06:39 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255056, encodeId=5e5d2550566f, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 22 09:19:51 CST 2017, time=2017-10-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1748858, encodeId=ae121e4885854, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636278, encodeId=421616362e8fe, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Sun Mar 18 02:38:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717567, encodeId=439d1e17567c0, content=<a href='/topic/show?id=c05be7634e8' target=_blank style='color:#2F92EE;'>#组合拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77634, encryptionId=c05be7634e8, topicName=组合拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed332427480, createdName=hxj0128, createdTime=Wed May 09 15:38:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797152, encodeId=a0781e97152b3, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 07 18:38:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463027, encodeId=e91d146302e3a, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Mon Oct 23 23:38:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255070, encodeId=c2582550e022, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 22 10:06:39 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255056, encodeId=5e5d2550566f, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 22 09:19:51 CST 2017, time=2017-10-22, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1748858, encodeId=ae121e4885854, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636278, encodeId=421616362e8fe, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Sun Mar 18 02:38:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717567, encodeId=439d1e17567c0, content=<a href='/topic/show?id=c05be7634e8' target=_blank style='color:#2F92EE;'>#组合拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77634, encryptionId=c05be7634e8, topicName=组合拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed332427480, createdName=hxj0128, createdTime=Wed May 09 15:38:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797152, encodeId=a0781e97152b3, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 07 18:38:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463027, encodeId=e91d146302e3a, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Mon Oct 23 23:38:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255070, encodeId=c2582550e022, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 22 10:06:39 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255056, encodeId=5e5d2550566f, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 22 09:19:51 CST 2017, time=2017-10-22, status=1, ipAttribution=)]
    2017-10-22 Y—xianghai

    学习了新知识

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1748858, encodeId=ae121e4885854, content=<a href='/topic/show?id=aed164e34b5' target=_blank style='color:#2F92EE;'>#治癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64734, encryptionId=aed164e34b5, topicName=治癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0d136204823, createdName=yinhl1990, createdTime=Sun May 13 02:38:00 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636278, encodeId=421616362e8fe, content=<a href='/topic/show?id=312b35662d6' target=_blank style='color:#2F92EE;'>#十九大#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35662, encryptionId=312b35662d6, topicName=十九大)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=219a22610756, createdName=12498974m58暂无昵称, createdTime=Sun Mar 18 02:38:00 CST 2018, time=2018-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1717567, encodeId=439d1e17567c0, content=<a href='/topic/show?id=c05be7634e8' target=_blank style='color:#2F92EE;'>#组合拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77634, encryptionId=c05be7634e8, topicName=组合拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ed332427480, createdName=hxj0128, createdTime=Wed May 09 15:38:00 CST 2018, time=2018-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797152, encodeId=a0781e97152b3, content=<a href='/topic/show?id=ddcc2254e7f' target=_blank style='color:#2F92EE;'>#中西医结#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22547, encryptionId=ddcc2254e7f, topicName=中西医结)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Wed Feb 07 18:38:00 CST 2018, time=2018-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463027, encodeId=e91d146302e3a, content=<a href='/topic/show?id=83312253524' target=_blank style='color:#2F92EE;'>#中西医#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22535, encryptionId=83312253524, topicName=中西医)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=693f6527574, createdName=lizhou0206, createdTime=Mon Oct 23 23:38:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255070, encodeId=c2582550e022, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Oct 22 10:06:39 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255056, encodeId=5e5d2550566f, content=谢谢分享. , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sun Oct 22 09:19:51 CST 2017, time=2017-10-22, status=1, ipAttribution=)]
    2017-10-22 doctorJiangchao

    谢谢分享.

    0

相关资讯

Eur J Neurol:中西医结合疗法在台湾阿尔茨海默病患者中的应用(全国性人群研究)

研究人员发现,与未接受中西医治疗者相比,中西医治疗的患者更年轻,且女性/男性比例更高,西药使用率更高。诊断与首次中医会诊的中位间隔为7.92个月。盐酸多奈哌齐和利斯的明是常用的处方药物。中药是在中西医治疗者中最受欢迎的治疗方法。

2016慢性心力衰竭中西医结合诊疗专家共识发布

本共识根据慢性心力衰竭(简称慢性心衰)的临床研究证据并结合专家经验制订,主要涉及成人慢性心衰的诊断和药物治疗 ,关键建议包括以下几个方面:(1)加用中医治疗可改善慢性心衰患者临床症状和生活质量,维持心功能,减少再住院率。(2)慢性心衰中医学认为属本虚标实之证,病机用“虚"、“瘀"、“水"概括,益气、活血、利水为心衰的治疗大法。(3)慢性心衰A、B阶段中医主要针对原发病辨证论治,B阶段尚可酌情选用具

JNCIM:中西医结合可减轻癌症患者疼痛和焦虑

疼痛是癌症和癌症治疗的副作用,治疗癌症相关的疼痛是卫生保健提供者的又一个挑战。Penny George研究所研究人员发表在Journal of the National Cancer Institute Monographs杂志上的研究发现,中西医结合疗法可以显著减轻癌症患者的疼痛和焦虑。经过中西医结合干预措施,如医疗按摩,针灸,引导图像或舒张反应干预,癌症患者经历的痛苦平均减少47%,焦虑减少5

国际规范大型多中心麝香保心丸随机双盲安慰剂对照研究揭盲——专家共议中西医结合的冠心病治疗之路

近日,由中国中西医结合学会心血管病专业委员会主办的第十五次全国中西医结合心血管学术会议暨福建省中西医结合学会心血管病学分会学术年会在福州召开。国医大师陈可冀院士、复旦大学附属中山医院葛均波院士等心血管病权威专家出席会议并围绕冠心病的中西医结合防治研究做了主题报告。

高血压性脑出血急性期中西医结合诊疗专家共识

全球疾病负担2013 报告指出,发展中国家的脑卒中死亡例数占全球75%;中国卒中协会2015 年报告指出,我国每年死于脑血管病的患者约130 万,卒中已经成为我国居民的第一位死亡原因,且中国人群卒中发病率明显高于世界平均水平。高血压性脑出血是高血压最严重的并发症之一,中药不仅可以改善高血压性脑出血的脑微循环,还能促进血肿吸收,改善神经功能预后,但缺乏多中心、随机对照研究支持未能被广泛应用,为此,北

2016勃起功能障碍中西医结合诊疗指南(试行版)发布

本指南参照英国牛津大学循证医学中心对循证级别提出的分类方法,参考国内外最新指南及研究成果制定,具有以下特点:①西医部分内容参考国内外最新指南和权威期刊文献,体现本指南内容的新颖性、科学性和指导性;②中医部分内容参考经典文献、教材和专著,保证指南内容的准确性、统一性;③国内众多知名中西医结合男科专家参与编写和讨论,确保指南的权威性、实用性和可操作性。全文获取:下载地址:指南下载 (需要扣积

Baidu
map
Baidu
map
Baidu
map